Skip to content
2000
image of Comparison of the Effect of Intermittent Fasting with Mediterranean Diet on Glycemic, Lipid, and Anthropometric Indices in Type 2 Diabetes: A Review of Randomized Controlled Trials

Abstract

Introduction

Type 2 diabetes is a metabolic disorder that is becoming more prevalent over time. Research has shown that the Mediterranean diet (MD) and intermittent fasting (IF) can improve the metabolic parameters of patients with type 2 diabetes. However, there has yet to be a study comparing the effectiveness of these two diets in diabetic patients. This review aims to compare the impact of the Mediterranean diet and intermittent fasting on glycemic, lipid, and anthropometric indices in patients with type 2 diabetes.

Methods

We selected clinical trial studies published between 2013 and 2023 that examined the impact of the MD and the IF diet on glycemic, lipid, and anthropometric indices in patients with type 2 diabetes, in the PubMed and Scopus databases on November 23, 2023, and were included in our study following the PRISMA guidelines.

Results

A total of 22 clinical trials meeting the inclusion criteria were chosen. Out of these, 13 clinical trials focused on the impact of the Mediterranean diet, while the remaining trials examined the effects of the IF diet on type 2 diabetes. The age range of participants in all studies was above 18 years, with the number of individuals investigated ranging from 9 to 557. The duration of the interventions varied from 1 week to 8 years. The MD and IF have both have been shown to effectively improve glycemic control, lipid profiles, and anthropometric measurements in patients with type 2 diabetes. However, the MD tends to offer more consistent and sustainable long-term benefits. This can be attributed to its rich composition of antioxidants, healthy fats, and dietary fiber. IF has demonstrated potential benefits for improving blood sugar levels and lipid profiles over short periods. However, its effectiveness may be compromised by the risk of hypoglycemia and the inconsistent commitment of patients.

Conclusion

These findings suggest that the MD is preferable for long-term, while IF may serve as a complementary short-term strategy. Further research in this area is necessary to provide a definitive opinion.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021351456250326051146
2025-04-11
2025-08-16
Loading full text...

Full text loading...

References

  1. 2. Classification and diagnosis of diabetes. Diabetes Care 2017 40 Suppl. 1 S11 S24 10.2337/dc17‑S005 27979889
    [Google Scholar]
  2. Derrick S.A. Nguyen S.T. Marthens J.R. Dambacher L.L. Sikalidis A.K. Reaves S.K. A Mediterranean-style diet improves the parameters for the management and prevention of type 2 diabetes mellitus. Medicina 2023 59 10 1882 10.3390/medicina59101882 37893600
    [Google Scholar]
  3. Harris M.F. The metabolic syndrome. Aust. Fam. Physician 2013 42 8 524 527 23971058
    [Google Scholar]
  4. Kahn S.E. Hull R.L. Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 7121 840 846 10.1038/nature05482 17167471
    [Google Scholar]
  5. Association A.D. 8. Obesity management for the treatment of type 2 diabetes: Standards of medical care in diabetes—2021. Diabetes Care 2021 44 Suppl. 1 S100 S110 10.2337/dc21‑S008 33298419
    [Google Scholar]
  6. Liu B. Hutchison A.T. Thompson C.H. Lange K. Heilbronn L.K. Markers of adipose tissue inflammation are transiently elevated during intermittent fasting in women who are overweight or obese. Obes. Res. Clin. Pract. 2019 13 4 408 415 10.1016/j.orcp.2019.07.001 31302012
    [Google Scholar]
  7. Evert A.B. Dennison M. Gardner C.D. Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care 2019 42 5 731 754 10.2337/dci19‑0014 31000505
    [Google Scholar]
  8. Papamichou D. Panagiotakos D.B. Itsiopoulos C. Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials. Nutr. Metab. Cardiovasc. Dis. 2019 29 6 531 543 10.1016/j.numecd.2019.02.004 30952576
    [Google Scholar]
  9. Rosato V. Temple N.J. La Vecchia C. Castellan G. Tavani A. Guercio V. Mediterranean diet and cardiovascular disease: A systematic review and meta-analysis of observational studies. Eur. J. Nutr. 2019 58 1 173 191 10.1007/s00394‑017‑1582‑0 29177567
    [Google Scholar]
  10. Salas-Salvadó J. Guasch-Ferré M. Lee C.H. Estruch R. Clish C.B. Ros E. Protective effects of the Mediterranean diet on type 2 diabetes and metabolic syndrome. J. Nutr. 2016 146 4 920S 927S 10.3945/jn.115.218487 26962178
    [Google Scholar]
  11. Alonso-Domínguez R. García-Ortiz L. Patino-Alonso M.C. Sánchez-Aguadero N. Gómez-Marcos M.A. Recio-Rodríguez J.I. Effectiveness of a multifactorial intervention in increasing adherence to the Mediterranean diet among patients with diabetes mellitus type 2: A controlled and randomized study (EMID Study). Nutrients 2019 11 1 162 10.3390/nu11010162 30646500
    [Google Scholar]
  12. Varady K.A. Cienfuegos S. Ezpeleta M. Gabel K. Clinical application of intermittent fasting for weight loss: Progress and future directions. Nat. Rev. Endocrinol. 2022 18 5 309 321 10.1038/s41574‑022‑00638‑x 35194176
    [Google Scholar]
  13. Koopman A.D.M. Rauh S.P. van ’t Riet E. The association between social jetlag, the metabolic syndrome, and type 2 diabetes mellitus in the general population: The new hoorn study. J. Biol. Rhythms 2017 32 4 359 368 10.1177/0748730417713572 28631524
    [Google Scholar]
  14. Vetter C. Dashti H.S. Lane J.M. Night shift work, genetic risk, and type 2 diabetes in the UK biobank. Diabetes Care 2018 41 4 762 769 10.2337/dc17‑1933 29440150
    [Google Scholar]
  15. Roden M. Perseghin G. Petersen K.F. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J. Clin. Invest. 1996 97 3 642 648 10.1172/JCI118460 8609218
    [Google Scholar]
  16. Izumida Y. Yahagi N. Takeuchi Y. Glycogen shortage during fasting triggers liver–brain–adipose neurocircuitry to facilitate fat utilization. Nat. Commun. 2013 4 1 2316 10.1038/ncomms3316 23939267
    [Google Scholar]
  17. Wang X. Li Q. Liu Y. Jiang H. Chen W. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res. Clin. Pract. 2021 179 109003 10.1016/j.diabres.2021.109003 34391831
    [Google Scholar]
  18. Corley B.T. Carroll R.W. Hall R.M. Weatherall M. Parry-Strong A. Krebs J.D. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: A randomized controlled trial. Diabet. Med. 2018 35 5 588 594 10.1111/dme.13595 29405359
    [Google Scholar]
  19. Yang X. Zhou J. Shao H. Effect of an intermittent calorie-restricted diet on type 2 diabetes remission: A randomized controlled trial. J. Clin. Endocrinol. Metab. 2023 108 6 1415 1424 10.1210/clinem/dgac661 36515429
    [Google Scholar]
  20. Teong X.T. Liu K. Vincent A.D. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: A randomized controlled trial. Nat. Med. 2023 29 4 963 972 10.1038/s41591‑023‑02287‑7 37024596
    [Google Scholar]
  21. Lasa A. Miranda J. Bulló M. Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes. Eur. J. Clin. Nutr. 2014 68 7 767 772 10.1038/ejcn.2014.1 24518752
    [Google Scholar]
  22. Maiorino M.I. Bellastella G. Petrizzo M. Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes: Follow-up of a randomized trial. Eur. J. Prev. Cardiol. 2017 24 4 399 408 10.1177/2047487316676133 27798369
    [Google Scholar]
  23. Muscogiuri G. Barrea L. Di Somma C. Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: A pilot study. Hormones 2019 18 1 75 84 10.1007/s42000‑018‑0090‑9 30644069
    [Google Scholar]
  24. Moher D Liberati A Tetzlaff J Altman DG Preferred reporting items for systematic reviews and meta-analyses: The PRISMA state-ment. Ann Intern Med 2009 151 4 264 269 W64 10.7326/0003‑4819‑151‑4‑200908180‑00135 19622511
  25. Morales-Suarez-Varela M. Collado Sánchez E. Peraita-Costa I. Llopis-Morales A. Soriano J.M. Intermittent fasting and the possible benefits in obesity, diabetes, and multiple Sclerosis: A systematic review of randomized clinical trials. Nutrients 2021 13 9 3179 10.3390/nu13093179 34579056
    [Google Scholar]
  26. Burns P.B. Rohrich R.J. Chung K.C. The levels of evidence and their role in evidence-based medicine. Plast. Reconstr. Surg. 2011 128 1 305 310 10.1097/PRS.0b013e318219c171 21701348
    [Google Scholar]
  27. Andriessen C. Fealy C.E. Veelen A. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: A randomised crossover trial. Diabetologia 2022 65 10 1710 1720 10.1007/s00125‑022‑05752‑z 35871650
    [Google Scholar]
  28. Carter S. Clifton P.M. Keogh J.B. The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res. Clin. Pract. 2016 122 106 112 10.1016/j.diabres.2016.10.010 27833048
    [Google Scholar]
  29. Carter S. Clifton P.M. Keogh J.B. The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res. Clin. Pract. 2019 151 11 19 10.1016/j.diabres.2019.03.022 30902672
    [Google Scholar]
  30. Obermayer A. Tripolt N.J. Pferschy P.N. Efficacy and safety of intermittent fasting in people with insulin-treated type 2 diabetes (INTERFAST-2)—A randomized controlled trial. Diabetes Care 2023 46 2 463 468 10.2337/dc22‑1622 36508320
    [Google Scholar]
  31. Kahleova H. Belinova L. Malinska H. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: A randomised crossover study. Diabetologia 2014 57 8 1552 1560 10.1007/s00125‑014‑3253‑5 24838678
    [Google Scholar]
  32. Li C. Sadraie B. Steckhan N. Effects of a one-week fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome – A randomized controlled explorative study. Exp. Clin. Endocrinol. Diabetes 2017 125 9 618 624 10.1055/s‑0043‑101700 28407662
    [Google Scholar]
  33. Al-Aubaidy H.A. Dayan A. Deseo M.A. Twelve-week Mediterranean diet intervention increases citrus bioflavonoid levels and reduces inflammation in people with type 2 diabetes mellitus. Nutrients 2021 13 4 1133 10.3390/nu13041133 33808180
    [Google Scholar]
  34. Esposito K. Maiorino M.I. Petrizzo M. Bellastella G. Giugliano D. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: Follow-up of a randomized trial. Diabetes Care 2014 37 7 1824 1830 10.2337/dc13‑2899 24722497
    [Google Scholar]
  35. Gomez-Marin B. Gomez-Delgado F. Lopez-Moreno J. Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: The Cordioprev randomized trial. Am. J. Clin. Nutr. 2018 108 5 963 970 10.1093/ajcn/nqy144 30475968
    [Google Scholar]
  36. Gudban N. Yehuda I. Nasir W. Soboh S. Tamir S. Blum A. Effect of telemedicine dietary intervention for endothelial function in patients with type 2 diabetes mellitus on Mediterranean diet. Isr. Med. Assoc. J. 2021 23 2 89 93 33595213
    [Google Scholar]
  37. Ismael S. Silvestre M.P. Vasques M. A pilot study on the metabolic impact of mediterranean diet in type 2 diabetes: Is gut microbiota the key? Nutrients 2021 13 4 1228 10.3390/nu13041228 33917736
    [Google Scholar]
  38. Jin S.M. Ahn J. Park J. Hur K.Y. Kim J.H. Lee M.K. East Asian diet‐mimicking diet plan based on the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet in adults with type 2 diabetes: A randomized controlled trial. J. Diabetes Investig. 2021 12 3 357 364 10.1111/jdi.13384 32772491
    [Google Scholar]
  39. Turner-McGrievy G.M. Wilson M.J. Carswell J. A 12-week randomized intervention comparing the healthy US, Mediterranean, and vegetarian dietary patterns of the US dietary guidelines for changes in body weight, hemoglobin A1c, blood pressure, and dietary quality among african american adults. J. Nutr. 2023 153 2 579 587 10.1016/j.tjnut.2022.11.020 36894249
    [Google Scholar]
  40. Zahedi Yazdi M. Akhlagh S. Aboomardani M. Alipoor R. Hosseini S. Rezaei Shahmirzadi A. Efficacy of Mediterranean diet on blood biochemical factors in type II diabetic patients: A randomized controlled trial. Gazi Medical Journal 2020 31 714 718
    [Google Scholar]
  41. Esposito K. Maiorino M.I. Bellastella G. Chiodini P. Panagiotakos D. Giugliano D. A journey into a Mediterranean diet and type 2 diabetes: A systematic review with meta-analyses. BMJ Open 2015 5 8 e008222 10.1136/bmjopen‑2015‑008222 26260349
    [Google Scholar]
  42. Calder P.C. Ahluwalia N. Brouns F. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011 106 S3 Suppl. 3 S5 S78 10.1017/S0007114511005460 22133051
    [Google Scholar]
  43. Silva A.I. Direito M. Pinto-Ribeiro F. Ludovico P. Sampaio-Marques B. Effects of intermittent fasting on regulation of metabolic homeostasis: A systematic review and meta-analysis in health and metabolic-related disorders. J. Clin. Med. 2023 12 11 3699 10.3390/jcm12113699 37297894
    [Google Scholar]
  44. Sutton E.F. Beyl R. Early K.S. Cefalu W.T. Ravussin E. Peterson C.M. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018 27 6 1212 1221.e3 10.1016/j.cmet.2018.04.010 29754952
    [Google Scholar]
  45. Papamichou D. Panagiotakos D.B. Holmes E. The rationale and design of a Mediterranean diet accompanied by time restricted feeding to optimise the management of type 2 diabetes: The MedDietFast randomised controlled trial. Nutr. Metab. Cardiovasc. Dis. 2022 32 1 220 230 10.1016/j.numecd.2021.09.031 34836715
    [Google Scholar]
/content/journals/chyr/10.2174/0115734021351456250326051146
Loading
/content/journals/chyr/10.2174/0115734021351456250326051146
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test